Sarepta Therapeutics (SRPT)

Nasdaq Health Care Biotechnology S&P SmallCap 600

$17.82

+0.25 (+1.42%)

Close of Nov 06, 2026 · end-of-day data

Source: Sarepta Therapeutics's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 09, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$5.42M	$154.58M	$301.03M	$380.83M	$540.10M	$701.89M	$933.01M	$1.24B	$1.90B	$2.20B
Cost of revenue	$130.00K	—	—	—	—	—	—	—	—	$25.50M
Gross profit	$5.29M	—	—	—	—	—	—	—	—	$2.17B
Research & development	$188.27M	$166.71M	$401.84M	$560.91M	$722.34M	$771.18M	$877.09M	$877.39M	$804.52M	$1.52B
Selling, general & admin	$83.75M	$122.68M	$207.76M	$284.81M	$317.88M	$282.66M	$451.42M	$481.87M	$557.87M	$491.72M
Operating income	-$266.73M	-$171.64M	-$343.63M	-$705.56M	-$564.16M	-$459.71M	-$536.20M	-$267.82M	$218.08M	-$699.78M
Interest expense	$1.89M	$5.80M	$33.71M	$30.67M	$59.95M	$63.52M	-$53.25M	-$22.01M	-$18.39M	-$38.14M
Pre-tax income	-$267.26M	-$48.63M	-$362.61M	-$713.88M	-$553.07M	-$418.95M	-$689.96M	-$520.10M	$260.77M	-$702.23M
Income tax	—	$2.06M	-$692.00K	$1.20M	$1.06M	-$168.00K	$13.53M	$15.88M	$25.54M	$11.19M
Net income	-$267.26M	-$50.69M	-$361.92M	-$715.08M	-$554.13M	-$418.78M	-$703.49M	-$535.98M	$235.24M	-$713.41M
EBITDA	-$261.12M	-$163.55M	-$331.38M	-$681.06M	-$537.25M	-$421.69M	-$494.34M	-$223.43M	$255.81M	-$655.26M
EPS (basic)	$-5.49	$-0.86	$-5.46	$-9.71	$-7.11	$-5.15	$-8.03	$-5.80	$2.47	$-7.13
EPS (diluted)	$-5.49	$-0.86	$-5.46	$-9.71	$-7.11	$-5.15	$-8.03	$-5.80	$2.34	$-7.13
Diluted shares	48.70M	58.82M	66.25M	73.61M	77.96M	81.26M	87.56M	92.40M	107.88M	100.12M
Gross margin	97.6%	—	—	—	—	—	—	—	—	98.8%
Operating margin	-4920.3%	-111.0%	-114.1%	-185.3%	-104.5%	-65.5%	-57.5%	-21.5%	11.5%	-31.8%
Net margin	-4930.2%	-32.8%	-120.2%	-187.8%	-102.6%	-59.7%	-75.4%	-43.1%	12.4%	-32.5%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$122.42M	$599.69M	$370.83M	$835.08M	$1.50B	$2.12B	$966.78M	$428.43M	$1.10B	$801.28M
Short-term investments	$195.43M	$479.37M	$803.08M	$289.67M	$435.92M	$0	$1.02B	$1.25B	$251.78M	$138.37M
Receivables	$5.23M	$29.47M	$49.04M	$90.88M	$101.34M	$152.99M	$214.63M	$400.33M	$601.99M	$398.23M
Inventory	$12.81M	$83.61M	$125.44M	$171.38M	$231.96M	$186.21M	$203.97M	$322.86M	$749.96M	$914.74M
Total current assets	$373.48M	$1.23B	$1.43B	$1.47B	$2.49B	$2.60B	$2.56B	$2.58B	$3.07B	$2.54B
Total assets	$424.10M	$1.31B	$1.64B	$1.82B	$2.98B	$3.15B	$3.13B	$3.26B	$3.96B	$3.35B
Total current liabilities	$75.42M	$88.33M	$173.69M	$264.77M	$416.03M	$452.73M	$619.60M	$653.66M	$731.68M	$1.10B
Short-term debt	—	—	—	—	—	—	$0	$105.48M	$0	$0
Long-term debt	$17.67M	$431.05M	$420.55M	—	—	$563.67M	$1.54B	$1.24B	$1.14B	$828.97M
Total debt	$17.67M	$431.05M	$420.55M	—	—	$563.67M	$1.54B	$1.34B	$1.14B	$828.97M
Total liabilities	$87.41M	$518.75M	$609.80M	$1.00B	$2.22B	$2.22B	$2.74B	$2.41B	$2.44B	$2.21B
Shareholders' equity	$336.69M	$789.22M	$1.03B	$818.19M	$761.76M	$928.01M	$384.95M	$859.34M	$1.53B	$1.14B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$245.82M	-$232.00M	-$388.66M	-$456.46M	$107.47M	-$443.17M	-$325.35M	-$500.99M	-$205.79M	-$205.48M
Capital expenditures	$5.34M	$12.00M	$61.16M	$59.63M	$82.20M	$38.49M	$30.82M	$76.11M	$136.96M	$101.97M
Free cash flow	-$251.16M	-$244.00M	-$449.82M	-$516.09M	$25.26M	-$481.66M	-$356.17M	-$577.10M	-$342.74M	-$307.45M
Investing cash flow	-$90.19M	-$178.81M	-$370.49M	$286.73M	-$121.72M	$495.41M	-$1.05B	-$165.80M	$755.56M	$69.64M
Financing cash flow	$378.13M	$888.08M	$530.15M	$642.55M	$682.32M	$561.57M	$232.51M	$125.00M	$124.81M	-$168.34M
Share buybacks	—	—	—	—	—	—	—	$0	$0	$25.01M
Stock-based compensation	$29.96M	$30.46M	$50.13M	$78.60M	$108.07M	$113.94M	$233.02M	$182.51M	$184.30M	$123.40M
Depreciation & amortization	$5.61M	$8.09M	$12.24M	$24.50M	$26.91M	$38.02M	$41.86M	$44.40M	$37.72M	$44.52M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$396.78M	$413.46M	$362.93M	$467.17M	$658.41M	$744.86M	$611.09M	$399.36M	$442.93M	$730.80M	$401.25M	$381.35M
Gross profit	—	$308.93M	$316.00M	$338.08M	$505.85M	$473.96M	$360.56M	$219.27M	-$29.10M	—	—	—
Research & development	$195.52M	$200.40M	$179.69M	$224.48M	$199.95M	$773.45M	$204.39M	$218.89M	$325.34M	$153.96M	$91.26M	$82.55M
Selling, general & admin	$131.70M	$127.00M	$138.80M	$128.20M	$163.87M	$133.63M	$137.90M	$91.89M	$128.30M	$108.95M	$107.60M	$118.61M
Operating income	$24.62M	$34.91M	-$701.00K	$22.20M	$161.68M	-$300.39M	$115.58M	-$103.39M	-$411.58M	$358.43M	$13.29M	-$9.04M
Interest expense	-$38.79M	-$4.17M	$4.83M	$4.92M	-$32.31M	-$4.50M	-$5.23M	$9.46M	-$57.33M	-$21.71M	-$21.51M	$21.62M
Pre-tax income	$40.37M	$41.45M	$13.58M	$34.01M	$171.74M	-$383.52M	$153.64M	-$64.67M	-$407.68M	$343.17M	-$1.75M	-$25.77M
Income tax	-$5.28M	$5.33M	$7.12M	$395.00K	$12.69M	$63.99M	-$43.25M	-$14.10M	$4.55M	$12.21M	$3.14M	$2.69M
Net income	$45.66M	$36.12M	$6.46M	$33.61M	$159.05M	-$447.51M	$196.89M	-$50.57M	-$412.23M	$330.96M	-$4.89M	-$28.46M
EBITDA	$36.00M	$43.65M	$8.02M	$32.00M	$172.14M	-$290.41M	$126.42M	-$84.94M	-$406.33M	$369.03M	$23.70M	-$3.14M
EPS (basic)	$0.76	$0.38	$0.07	$0.35	$1.65	$-4.60	$2.01	$-0.50	$-3.93	$3.15	$-0.05	$-0.27
EPS (diluted)	$0.76	$0.37	$0.07	$0.34	$1.50	$-4.60	$1.89	$-0.50	$-3.93	$2.88	$-0.05	$-0.27
Diluted shares	—	99.11M	99.14M	100.45M	—	97.36M	106.62M	100.24M	—	121.92M	105.43M	105.93M
Gross margin	—	74.7%	87.1%	72.4%	76.8%	63.6%	59.0%	54.9%	-6.6%	—	—	—
Operating margin	6.2%	8.4%	-0.2%	4.8%	24.6%	-40.3%	18.9%	-25.9%	-92.9%	49.0%	3.3%	-2.4%
Net margin	11.5%	8.7%	1.8%	7.2%	24.2%	-60.1%	32.2%	-12.7%	-93.1%	45.3%	-1.2%	-7.5%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$428.43M	$427.29M	$383.62M	$197.85M	$1.10B	$240.87M	$510.60M	$613.08M	$801.28M	$464.45M	$571.15M	$472.76M
Short-term investments	$1.25B	$963.45M	$1.08B	$1.00B	$251.78M	$281.89M	$289.54M	$237.92M	$138.37M	$188.74M	$217.34M	$406.02M
Receivables	$400.33M	$378.81M	$360.00M	$434.52M	$601.99M	$659.37M	$527.29M	$395.74M	$398.23M	$394.82M	$376.82M	$369.18M
Inventory	$322.86M	$373.53M	$485.80M	$565.92M	$749.96M	$941.43M	$994.04M	$1.08B	$914.74M	$1.00B	$904.27M	$876.12M
Total current assets	$2.58B	$2.46B	$2.68B	$2.69B	$3.07B	$2.43B	$2.66B	$2.72B	$2.54B	$2.31B	$2.22B	$2.27B
Total assets	$3.26B	$3.22B	$3.42B	$3.60B	$3.96B	$3.47B	$3.68B	$3.49B	$3.35B	$3.18B	$3.19B	$3.17B
Total current liabilities	$653.66M	$608.71M	$688.49M	$699.49M	$731.68M	$605.59M	$919.95M	$921.42M	$1.10B	$499.16M	$502.91M	$656.35M
Short-term debt	$105.48M	$105.59M	$91.50M	$91.59M	$0	—	—	—	$0	—	—	$157.97M
Long-term debt	$1.24B	$1.24B	$1.23B	$1.23B	$1.14B	—	—	$140.50M	$828.97M	$838.16M	$847.62M	$857.36M
Total debt	$1.34B	$1.34B	$1.32B	$1.32B	$1.14B	—	—	$140.50M	$828.97M	$838.16M	$847.62M	$1.02B
Total liabilities	$2.41B	$2.26B	$2.35B	$2.38B	$2.44B	$2.32B	$2.32B	$2.17B	$2.21B	$1.67B	$1.66B	$1.64B
Shareholders' equity	$859.34M	$961.19M	$1.08B	$1.22B	$1.53B	$1.19B	$1.40B	$1.50B	$1.14B	$1.51B	$1.53B	$1.53B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	-$54.66M	-$242.08M	$14.94M	-$70.70M	$92.05M	-$583.44M	$261.34M	-$14.59M	$131.21M	-$202.68M	$197.07M	$59.97M
Capital expenditures	$19.04M	$32.44M	$29.17M	$37.26M	$38.08M	$43.65M	$31.80M	$22.93M	$3.59M	$2.08M	$555.00K	$2.93M
Free cash flow	-$73.70M	-$274.52M	-$14.22M	-$107.96M	$53.96M	-$627.09M	$229.54M	-$37.52M	$127.61M	-$204.76M	$196.51M	$57.03M
Investing cash flow	-$64.36M	$218.80M	-$98.53M	-$128.82M	$764.12M	-$291.18M	$32.21M	$232.40M	$96.21M	-$134.39M	-$93.37M	-$158.35M
Financing cash flow	$1.94M	$22.14M	$39.92M	$13.76M	$48.99M	$12.47M	-$23.82M	-$117.79M	-$39.21M	$241.00K	$0	$0
Share buybacks	—	—	—	$0	$0	—	—	$0	$0	—	—	—
Stock-based compensation	$45.83M	$40.69M	$50.48M	$43.45M	$49.68M	$41.43M	$37.02M	$14.93M	$30.02M	$29.40M	$24.47M	$26.74M
Depreciation & amortization	$11.37M	$8.74M	$8.72M	$9.81M	$10.46M	$9.98M	$10.84M	$18.45M	$5.25M	$10.59M	$10.41M	$5.90M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.